Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junlong Wu

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Cancer|December 15, 2018
Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset diseaseJunlong Wu, Hongkai Wang, Christopher J Ricketts, et al.
Frontiers in Genetics|October 2, 2019
Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical CarcinomaWen-Hao Xu, Junlong Wu, Jun Wang, et al.
International Urology and Nephrology|September 26, 2019
Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasisShengming Jin, Junjie Wang, Yijun Shen, et al.
Stem Cell Research & Therapy|January 17, 2019
BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signalingRui Zuo, Minghan Liu, Yanqiu Wang, et al.
Aging|August 26, 2019
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinomaWen-Hao Xu, Yue Xu, Jun Wang, et al.
Stem Cell Research & Therapy|January 25, 2020
Correction to: BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signalingRui Zuo, Minghan Liu, Yanqiu Wang, et al.
BMC Cancer|May 25, 2024
Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapyBeihe Wang, Jian Pan, Tingwei Zhang, et al.
Cell Reports. Medicine|March 8, 2025
Neoadjuvant fuzuloparib combined with abiraterone for localized high-risk prostate cancer (FAST-PC): A single-arm phase 2 studyTingwei Zhang, Beihe Wang, Yu Wei, et al.
Molecular Oncology|August 16, 2023
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparityYu Wei, Tingwei Zhang, Beihe Wang, et al.
Acta Biomaterialia|April 5, 2022
In situ regeneration of bone-to-tendon structures: Comparisons between costal-cartilage derived stem cells and BMSCs in the rat modelRui Zuo, Jiabin Liu, Yi Zhang, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Cancer|December 15, 2018
Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset diseaseJunlong Wu, Hongkai Wang, Christopher J Ricketts, et al.
Frontiers in Genetics|October 2, 2019
Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical CarcinomaWen-Hao Xu, Junlong Wu, Jun Wang, et al.
International Urology and Nephrology|September 26, 2019
Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasisShengming Jin, Junjie Wang, Yijun Shen, et al.
Stem Cell Research & Therapy|January 17, 2019
BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signalingRui Zuo, Minghan Liu, Yanqiu Wang, et al.
Aging|August 26, 2019
Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinomaWen-Hao Xu, Yue Xu, Jun Wang, et al.
Stem Cell Research & Therapy|January 25, 2020
Correction to: BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/β-catenin signalingRui Zuo, Minghan Liu, Yanqiu Wang, et al.
BMC Cancer|May 25, 2024
Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapyBeihe Wang, Jian Pan, Tingwei Zhang, et al.
Cell Reports. Medicine|March 8, 2025
Neoadjuvant fuzuloparib combined with abiraterone for localized high-risk prostate cancer (FAST-PC): A single-arm phase 2 studyTingwei Zhang, Beihe Wang, Yu Wei, et al.
Molecular Oncology|August 16, 2023
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparityYu Wei, Tingwei Zhang, Beihe Wang, et al.
Acta Biomaterialia|April 5, 2022
In situ regeneration of bone-to-tendon structures: Comparisons between costal-cartilage derived stem cells and BMSCs in the rat modelRui Zuo, Jiabin Liu, Yi Zhang, et al.
Pageof 13